Abbott India
₹26,170+100.00 (+0.38%)as of 2026-10-16
- Market Cap
- ₹55,678Cr.
- P/E Ratio
- 34.5
- P/B Ratio
- 11.65
- EPS (TTM)
- ₹758.55
- Day Range
- ₹25,910 – ₹26,230
- Div Yield
- 2.04%
- ROCE
- 44.8%
- ROE
- 34.4%
52W Low: ₹25,13552W High: ₹30,655
Themes:💊 Pharma & CDMO
Appears in 1 screen
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 9.0% a year over three years.
- Debt is 0.04× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Abbott_India — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 34.5P/E: 34.5 | P/B: 11.65Growth
ModestSales CAGR — 3Y: 9% · 1Y: 6%Profitability
High MarginROCE: 44.8% | ROE: 34.4%Key Metrics
Valuation
PEG Ratio 1.92
Price / Sales 7.95x
Price / FCF 42.6x
Book Value ₹2247
Margins & returns
Operating Margin 28%
Net Margin 23.1%
Return on Assets 24.8%